Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation

Background: The pharmacological cardioversion of recent-onset atrial fibrillation (AF) is a challenge for the clinician. The aim of the study was to compare the efficacy, the safety, and the overall cost of intravenous (iv) administration of vernakalant, which is a relatively new atrial-selective an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Hippokratia
Hoofdauteurs: Vogiatzis, I, Papavasiliou, E, Dapcevitch, I, Pittas, S, Koulouris, E
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL" 2017
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239091/
https://ncbi.nlm.nih.gov/pubmed/30455558
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items